These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26679968)

  • 1. Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes.
    Tan E; Yang W; Pang B; Dai M; Loh FE; Hogan P
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1195-202. PubMed ID: 26679968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population.
    Grabner M; Peng X; Geremakis C; Bae J
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1204-12. PubMed ID: 26679969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Reduced Drug Copayments on Adherence to Oral Diabetes Medications Among Childless Adults in Wisconsin Medicaid.
    Kim NH; Look KA
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1432-1441. PubMed ID: 31778619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 diabetes detection and management among insured adults.
    Dall TM; Yang W; Halder P; Franz J; Byrne E; Semilla AP; Chakrabarti R; Stuart B
    Popul Health Metr; 2016; 14():43. PubMed ID: 27895533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence and Persistence with DPP-4 Inhibitors Versus Pioglitazone in Type 2 Diabetes Patients with Chronic Kidney Disease: A Retrospective Claims Database Analysis.
    Gor D; Lee TA; Schumock GT; Walton SM; Gerber BS; Nutescu EA; Touchette DR
    J Manag Care Spec Pharm; 2020 Jan; 26(1):67-75. PubMed ID: 31880221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alignment of diagnosis and pharmacy claims data coding of medication adherence among patients with diabetes or hypertension.
    Gatwood J; Hohmeier KC; Shuvo S; Mikaiel D; Kovesdy CP
    J Manag Care Spec Pharm; 2021 Apr; 27(4):497-506. PubMed ID: 33769854
    [No Abstract]   [Full Text] [Related]  

  • 7. A Retrospective Database Study Comparing Diabetes-Related Medication Adherence and Health Outcomes for Mail-Order Versus Community Pharmacy.
    Schwab P; Racsa P; Rascati K; Mourer M; Meah Y; Worley K
    J Manag Care Spec Pharm; 2019 Mar; 25(3):332-340. PubMed ID: 30816817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members.
    Jing S; Naliboff A; Kaufman MB; Choy M
    J Manag Care Pharm; 2011 Jun; 17(5):355-66. PubMed ID: 21657805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
    Chinthammit C; Axon DR; Mollon L; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data.
    McAdam-Marx C; Bellows BK; Unni S; Wygant G; Mukherjee J; Ye X; Brixner DI
    J Manag Care Spec Pharm; 2014 Jul; 20(7):691-700. PubMed ID: 24967522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes Drugs.
    Saundankar V; Peng X; Fu H; Ascher-Svanum H; Rodriguez A; Ali A; Slabaugh L; Young P; Louder A
    J Manag Care Spec Pharm; 2016 May; 22(5):467-82. PubMed ID: 27123910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
    Abughosh SM; Wang X; Serna O; Henges C; Masilamani S; Essien EJ; Chung N; Fleming M
    J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.
    Iyengar RN; LeFrancois AL; Henderson RR; Rabbitt RM
    J Manag Care Spec Pharm; 2016 May; 22(5):550-60. PubMed ID: 27123916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Rates of Nonadherence to Antihypertensive Medications Among Insured Adults With Hypertension, 2015.
    Chang TE; Ritchey MD; Park S; Chang A; Odom EC; Durthaler J; Jackson SL; Loustalot F
    Hypertension; 2019 Dec; 74(6):1324-1332. PubMed ID: 31679429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
    Mhatre SK; Serna O; Sansgiry S; Fleming ML; Essien EJ; Sansgiry SS
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIV.
    Dunn K; Lafeuille MH; Jiao X; Romdhani H; Emond B; Woodruff K; Pesa J; Tandon N; Lefebvre P
    J Manag Care Spec Pharm; 2018 Oct; 24(10):1040-1051. PubMed ID: 29877140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Patterns and Characteristics of Individuals Initiating High-Dose Insulin for Type 2 Diabetes Mellitus.
    Chen J; Nair R; Siadaty M; Brown K; Meah Y; Taylor AD; He X; Fan L
    J Manag Care Spec Pharm; 2020 Jul; 26(7):839-847. PubMed ID: 32584684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes.
    Bibeau WS; Fu H; Taylor AD; Kwan AY
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1338-1347. PubMed ID: 27783549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic variation in medication adherence in commercial and Medicare part D populations.
    Couto JE; Panchal JM; Lal LS; Bunz TJ; Maesner JE; O'Brien T; Khan T
    J Manag Care Spec Pharm; 2014 Aug; 20(8):834-42. PubMed ID: 25062077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of medication synchronization programs on proportion of days covered (PDC) scores and Medicare Part D medication-related adherence metrics.
    Bernard K; Cowles B; McCall K; Henningsen RM; O'Toole M; Tu C
    J Am Pharm Assoc (2003); 2019; 59(3):343-348. PubMed ID: 30940515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.